Search clinical trials for: MK0826, ertapenem sodium

Total 10629 results

Merck Sharp & Dohme LLC

Completed

Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055)

Urinary Tract Infection
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Safety, Tolerability and Efficacy of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-048)

Urinary Tract Infection
Merck Sharp & Dohme LLC

Completed

To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053)

Sepsis
Merck Sharp & Dohme LLC

Completed

To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052)

Pneumonia | Urinary Tract Infection | Infection
Merck Sharp & Dohme LLC

Completed

A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)

Colorectal Surgery
Merck Sharp & Dohme LLC

Completed

Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)

Urinary Tract Infections | Soft Tissue Infections | Bacterial Pneumonia
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)

Complicated Intra-abdominal Infection
Merck Sharp & Dohme LLC

Terminated

Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)

Urinary Tract Infections
Merck Sharp & Dohme LLC

Completed

An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)

Infections | Pelvic Infections
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)(0736-003)(COMPLETED)

Hypertension
Merck Sharp & Dohme LLC

Completed

Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)

Foot Infections in Diabetic Patients
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety of Ertapenem Sodium (MK-0826) Following Colorectal Surgery in Chinese Adults (MK-0826-056)

Surgical Site Infection | Infection
Merck Sharp & Dohme LLC

Completed

Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061)

Infection; Diabetic Foot
University Medical Center Groningen

Completed

PK/PD of Ertapenem In Patients With TB

PK of Ertapenem in TB Patients

Netherlands
Merck Sharp & Dohme LLC

Terminated

A 52-Week Study to Assess the Effects of MK0822 on Knee Osteoarthritis (MK-0822-011)

Osteoarthritis

United States, Chile, Colombia, Mexico, Poland
University of Michigan

Completed

Pharmacokinetics of Ertapenem in Continuous Venovenous Hemodialysis

Acute Kidney Failure

United States
Catholic University of the Sacred Heart
Merck Sharp & Dohme LLC

Unknown

Safety of Ertapenem in Beta-lactam Allergic Patients.

Allergy | IgE-Mediated Hypersensitivity

Italy
Hartford Hospital
Merck Sharp & Dohme LLC

Completed

Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion

Healthy

United States
HaEmek Medical Center, Israel

Withdrawn

Penetration of Ertapenem Into Bone

Amputation

Israel
Klinikum Hanover-Siloah Hospital

Unknown

Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis

Acute Disease | Diverticulitis, Colonic

Germany
Prince of Songkla University

Unknown

Ertapenem in Patients With Urosepsis

Patients With Urosepis and Received Ertapenem for Treatment

Thailand
Albany College of Pharmacy and Health Sciences
Merck Sharp & Dohme LLC

Completed

Ertapenem Pharmacokinetics in Patients in Continuous Ambulatory Peritoneal Dialysis

End Stage Renal Disease | Continuous Ambulatory Peritoneal Dialysis

United States
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Effects of a Light Breakfast on the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822)

Osteoporosis
Merck Sharp & Dohme LLC

Withdrawn

A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030)

Prostate Cancer
Merck Sharp & Dohme LLC

Completed

Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002)

Osteoporosis
Merck Sharp & Dohme LLC

Completed

Safety and Tolerability of Odanacatib (0822-059)

Osteoporosis
Merck Sharp & Dohme LLC

Completed

A Study to Test Once-Weekly Doses of Odanacatib (MK0822) on Healthy Adult Females (0822-005)(COMPLETED)

Osteoporosis
Merck Sharp & Dohme LLC

Completed

Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)

Complicated Intra-Abdominal Infections
Olive View-UCLA Education & Research Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Pilot Trial of Antibiotics Versus Surgery for Treating Acute Appendicitis

Acute Uncomplicated Appendicitis

United States
Merck Sharp & Dohme LLC

Completed

Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)

Post-Menopausal Osteoporosis
Merck Sharp & Dohme LLC

Completed

MK0686 in Postsurgery Dental Pain (0686-002)

Pain, Postoperative
Merck Sharp & Dohme LLC

Terminated

A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)

Relapsing-Remitting Multiple Sclerosis
Merck Sharp & Dohme LLC

Completed

MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005)

Diabetes Mellitus, Type 2 | Metabolic Syndrome
Merck Sharp & Dohme LLC

Completed

MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)

Seasonal Allergies
Merck Sharp & Dohme LLC

Terminated

A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)

Neuralgia, Postherpetic
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Safety and Efficacy of an Investigational Drug (MK-686) in Patients With Osteoarthritis (0686-006)

Osteoarthritis
Henry Ford Health System

Withdrawn

A Single Center, Prospective Clinical Trial of Intravenous Ertapenem in the Treatment of Hurley Stage II or III Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States
University Hospital, Bordeaux

Completed

Pharmacokinetics of Ertapenem in Patients Aged Over 75 (PHACINERTA)

Infections

France
Nantes University Hospital

Completed

Pharmacokinetics Ertapenem Burns

Burn Patients

France
Sihuan Pharmaceutical Holdings Group Ltd.

Completed

A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Complicated Urinary Tract Infection Including Acute Pyelonephritis

China
Daniel Benjamin

Terminated

Pharmacokinetics and Safety of Ertapenem in the Postpartum Period

Endometritis

United States
University of Delaware

Completed

Adverse Neurogenic Actions of Dietary Salt

Blood Pressure

United States
A.O. Ospedale Papa Giovanni XXIII

Unknown

Antibiotics Versus Surgery in Acute Appendicitis (ASAA)

Acute Appendicitis Without Peritonitis

Italy
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia

Community Acquired Pneumonia

China
Assistance Publique - Hôpitaux de Paris
Merck Sharp & Dohme LLC

Completed

Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration (ERTAPRO)

Benign Prostatic Hyperplasia (BPH) Requiring Surgical Resection

France
Todd C. Lee MD MPH FIDSA

Recruiting

Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia (CERT)

Staphylococcus Aureus Bacteremia | Staphylococcus Aureus Endocarditis | Staphylococcus Aureus Septicemia | Staphylococcal Sepsis

Canada
William Beaumont Hospitals
Wayne State University

Completed

Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis Patients

End Stage Renal Disease

United States
National University Hospital, Singapore
Merck Sharp & Dohme LLC

Unknown

An Observational Study of Ertapenem in Outpatient Parenteral Antibiotic Therapy (OPAT) for Complicated Urinary Tract Infections.

Urinary Tract Infections

Singapore
Poitiers University Hospital

Completed

Comparison of Ertapenem Distribution in the Muscle of Six Healthy Volunteers and Six Critically Ill Patients by Microdialysis

Healthy

France
Instituto Nacional de Cancer, Brazil

Terminated

Ertapenem Administered Subcutaneously Versus Intravenously

Urinary Tract Infections

Brazil

3

Subscribe